Clinigenが日本で初めて承認した超低出生体重児向け新薬とは Clinigenがプロラクタ社の「プリミーフォート®経腸用液」を日本で承認。超低出生体重児の栄養管理に新たな道を開く。未承認の技術を活用した医療革新の話題を掘り下げます。

Clinigenが日本で初めて承認した超低出生体重児向け新薬とは #医薬品 #Clinigen #プロラクタ

Clinigenがプロラクタ社の「プリミーフォート®経腸用液」を日本で承認。超低出生体重児の栄養管理に新たな道を開く。未承認の技術を活用した医療革新の話題を掘り下げます。

Clinigen Achieves Historic First with Approval of PreemieFort® Enteral Solution in Japan Clinigen's approval of PreemieFort® Enteral Solution in Japan marks a significant milestone in neonatal care. This first of its kind human milk-based product enhances nutrition for vulnerable infants.

Clinigen Achieves Historic First with Approval of PreemieFort® Enteral Solution in Japan #Japan #Tokyo #Prolacta #Clinigen #PreemieFort®

Santhera Enters into Supply and Distribution Agreement for AGAMREE (Vamorolone) with Clinigen Group "We look forward to working with Santhera to make AGAMREE available to patients globally on an unlicensed basis in those territories where it is not currently licensed or reimbursed. ” said Julie Gosper, Senior Vice President, Europe and Partner Markets at Clinigen. Santhera Pharmaceuticals announces the signing of an exclusive agreement with Clinigen Group to manage the supply and distribution of AGAMREE® (vamorolone) in countries where the product is not otherwise commercially available. Santhera Pharmaceuticals and Clinigen Group announce that they have signed a Supply and Distribution Agreement for AGAMREE in countries where the product can currently not be commercially obtained via Santhera or one of its current distribution partners. The agreement will enable access to AGAMREE on a case-by-case basis for patients with Duchenne muscular dystrophy (DMD) in situations where the treating physician deems there to be no suitable alternatives and where regulations allow for it. This agreement allows Santhera to receive the majority share of revenue generated from the supply of product in these additional countries.

Santhera Enters into Supply and Distribution Agreement for AGAMREE (Vamorolone) with Clinigen Group

👉 Read More: dmdwarrior.com

#dmd #duchenne #bmd #becker #dmdwarrior #dmdwarriors #duchennewarriors #duchennesmusculardystrophy #duchenne #agamree #vamorolone #santhera #Clinigen #clinigengroup